Apalutamide (APA) for metastatic castration-sensitive prostate cancer (mCSPC) in TITAN: Outcomes in patients (pts) with low- and high-risk disease
Author
Ozguroglu, Mustafa
Merseburger, Axel Stuart
Agarwal, Neeraj
Chung, Byung Ha
Uemura, Hirotsugu
Bjartell, Anders
Chowdhury, Simon
Chi, Kim N.
McCarthy, Sharon Anne
Larsen, Julie S.
Bhaumik, Amitabha
Lopez-Gitlitz, Angela
Soto, Alvaro Juarez
Metadata
Show full item recordCollections
- Bildiri [64839]